default author photo

A. Rouf Banday

Government of the United States of America - Laboratory of Translational Genomics

Bethesda, MD 20892

United States

SCHOLARLY PAPERS

2

DOWNLOADS

232

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

APOBEC Mutagenesis and Copy Number Alterations are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors

Number of pages: 93 Posted: 17 Jul 2018
Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Laboratory of Translational Genomics, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Government of the United States of America - Genetics Branch, Government of the United States of America - Genetics Branch, Government of the United States of America - National Center for Biotechnology Information, Government of the United States of America - National Center for Biotechnology Information, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch, Walter Reed National Military Medical Center, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, National Institute of Health (NIH) - Genetics Branch, Government of the United States of America - Laboratory of Translational Genomics and Government of the United States of America - Thoracic and Gastrointestinal Oncology Branch
Downloads 118 (604,538)
Citation 1

Abstract:

Loading...

2.

Final Results from a Phase 1 Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or with Ipilimumab for Advanced/Metastatic Genitourinary Tumours

Number of pages: 73 Posted: 26 Jun 2023
National Institutes of Health (NIH) - Bladder Cancer Section, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Biostatistics and Data Management Section, National Institutes of Health - Developmental Therapeutics Branch, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Laboratory of Translational Genomics, Government of the United States of America - Center for Cancer Research, National Institutes of Health (NIH) - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Laboratory of Pathology, Government of the United States of America - Clinical Center, Government of the United States of America - Clinical Center, Government of the United States of America - Center for Cancer Research, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - Urologic Oncology Branch, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - National Cancer Institute, Government of the United States of America - Division of Cancer Prevention, National Institutes of Health (NIH) - Clinical Immunotherapy Section, Rutgers University, New Brunswick - Rutgers Cancer Institute of New Jersey, City of Hope - Comprehensive Cancer Center, University of Southern California, Columbia University - Herbert Irving Comprehensive Cancer Center, University of California, Davis - Comprehensive Cancer Center, Government of the United States of America - Center for Cancer Research and Ohio State University (OSU) - Department of Internal Medicine
Downloads 114 (621,896)

Abstract:

Loading...

Urothelial Carcinoma, Rare Genitourinary Tumours, Immunotherapy, Immune Correlates Of Antitumor Response, Renal Medullary Carcinoma, Bladder Squamous Cell Carcinoma, Squamous Cell Carcinoma Of The Penis, Bladder Adenocarcinoma, Urachal Carcinoma, Cabozantinib